Inhibitors of cathepsin G: a patent review (2005 to present)

Bibliography

• Takahashi H, Nukiwa T, Yoshimura K, et al. Structure of the human neutrophil elastase gene. J Biol Chem 1988;263:14739-47
   PubMed Web of Science ®Google Scholar
• Bories D, Raynal MC, Solomon DH, et al. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 1989;59:959-68
   PubMed Web of Science ®Google Scholar
• Campanelli D, Melchior M, Fu Y, et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 1990;172:1709-15
   PubMed Web of Science ®Google Scholar
• Morgan JG, Sukiennicki T, Pereira HA, et al. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J Immunol 1991;147:3210-14
   Google Scholar
• Almeida RP, Melchior M, Campanelli D, et al. Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases. Biochem Biophys Res Commun 1991;177:688-95
   PubMedGoogle Scholar
• Perera NC, Schilling O, Kittel H, et al. NSP4, an elastase-related protease in human neutrophils with arginine specificity. Proc Natl Acad Sci USA 2012;109:6229-34
   PubMed Web of Science ®Google Scholar
• Hudig D, Ewoldt GR, Woodard SL. Proteases and lymphocyte cytotoxic killing mechanisms. Curr Opin Immunol 1993;5:90-6
   Google Scholar
• Haddad P, Jenne D, Tschopp J, et al. Structure and evolutionary origin of the human granzyme H gene. Int Immunol 1991;3:57-66
   Google Scholar
• Hanson RD, Hohn PA, Popescu NC, Ley TJ. A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human alpha/delta T-cell receptor locus. Proc Natl Acad Sci USA 1990;87:960-3
   PubMedGoogle Scholar
• Pagano MB, Bartoli MA, Ennis TL, et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci USA 2007;104:2855-60
   PubMed Web of Science ®Google Scholar
• Hermant B, Bibert S, Concord E, et al. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem 2003;278:14002-12
   PubMed Web of Science ®Google Scholar
• Bangalore N, Travis J, Onunka VC, et al. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem 1990;265:13584-8
   Google Scholar
• Shafer WM, Pohl J, Onunka VC, et al. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem 1991;266:112-6
   Google Scholar
• Renesto P, Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Blood 1993;82:139-44
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516
   PubMed Web of Science ®Google Scholar
• Owen CA, Campbell EJ. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 1998;160:1436-43
   PubMed Web of Science ®Google Scholar
• Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett 1989;249:353-6
   PubMed Web of Science ®Google Scholar
• Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 2005;118:2325-40
   PubMed Web of Science ®Google Scholar
• Dzau VJ. Evolving concepts of the renin-angiotensin system. Focus on renal and vascular mechanisms. Am J Hypertens 1988;1:334S-7S
   Google Scholar
• Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2008;28:2108-14
   PubMed Web of Science ®Google Scholar
• Keeling WB, Armstrong PA, Stone PA, et al. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005;39:457-64
   PubMedGoogle Scholar
• Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-12
   PubMed Web of Science ®Google Scholar
• Lu H, Rateri DL, Cassis LA, Daugberty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep 2008;10:99-106
   PubMed Web of Science ®Google Scholar
• Fontaine V, Touat Z, Mtairagel M, et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004;164:2077-87
   PubMed Web of Science ®Google Scholar
• Chatham WW, Blackburn WD Jr, Heck LW. Additive enhancement of neutrophil collagenase activity by HOCl and cathepsin G. Biochem Biophys Res Commun 1992;184:560-7
   Google Scholar
• Hans SS, Jareunpoon O, Balasubramaniam M, Zelenock GB. Size and location of thrombus in intact and ruptured abdominal aortic aneurysms. J Vasc Surg 2005;41:584-8
   PubMed Web of Science ®Google Scholar
• Gacko M, Chyczewski L. Activity and localization of cathepsin B, D and G in aortic aneurysm. Int Surg 1997;82:398-402
   PubMed Web of Science ®Google Scholar
• Kaschina E, Scholz H, Steckelings UM, et al. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 2009;205:396-403
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010;62(4):726-59
   PubMed Web of Science ®Google Scholar
• Baumann M, Pham CT, Benarafa C. SerpinB1 is critical for neutrophil survival through cell-autonomous inhibition of cathepsin G. Blood 2013;121:3900-7
   PubMed Web of Science ®Google Scholar
• Scott FL, Hirst CE, Sun J, et al. The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G. Blood 1999;93:2089-97
   PubMed Web of Science ®Google Scholar
• Fath MA, Wu X, Hileman RE, et al. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J Biol Chem 1998;273:13563-9
   PubMed Web of Science ®Google Scholar
• Campbell EJ, Campbell MA, Boukedes SS, Owen CA. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. J Clin Invest 1999;104:337-44
   PubMed Web of Science ®Google Scholar
• Rao NV, Marshall BC, Gray BH, Hoidal JR. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol 1993;8:612-16
   PubMedGoogle Scholar
• Owen CA, Campbell MA, Boukedes SS, Campbell EJ. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J Immunol 1995;155:5803-10
   PubMedGoogle Scholar
• Korkmaz B, Attucci S, Jourdan ML, et al. Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J Immunol 2005;175:3329-38
   Google Scholar
• Dubois AV, Gauthier A, Brea D, et al. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Am J Respir Cell Mol Biol 2012;47:80-6
   PubMed Web of Science ®Google Scholar
• Lefrançais E, Roga S, Gautier V, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 2012;109:1673-8
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Nannuru KC, Singh RK. Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1. Cancer Res 2009;69:3188-95
   Google Scholar
• Perrin J, Lecompte T, Tournier A, et al. In vitro effects of human neutrophil cathepsin G on thrombin generation: both acceleration and decreased potential. Thromb Haemost 2010;104:514-22
   Google Scholar
• McGowan SE. Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils. Am J Respir Cell Mol Biol 1990;2:271-9
   PubMed Web of Science ®Google Scholar
• Flodgaard H. The role of neutrophilic secretion products in infectious diseases. Contrib Microbiol 2003;10:75-85
   Google Scholar
• Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001;69:197-206
   PubMed Web of Science ®Google Scholar
• Kuester D, Lippert H, Roessner A, Krueger S. The cathepsin family and their role in colorectal cancer. Pathol Res Pract 2008;204:491-500
   PubMed Web of Science ®Google Scholar
• Snider GL. Experimental studies on emphysema and chronic bronchial injury. Eur J Respir Dis Suppl 1986;146:17-35
   PubMedGoogle Scholar
• Ley AC, Ladner RC, Guterman S, et al. Inhibitors of Human Neutrophil Elastase and Human Cathepsin G. WO015605A2; 1992
   Google Scholar
• Ladner RC, Guterman SK, Roberts BL, et al. Protein Engineering Corp. Cambridge MA Directed evolution of novel binding proteins. US5571698; 1993
   Google Scholar
• Ley AC, Guterman SK, Markland W, et al. Kunitz domain mutants as cathepsin G inhibitors. US0223977A1; 2003
   Google Scholar
• Bode W, Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta 2000;1477:241-52
   PubMed Web of Science ®Google Scholar
• Krowarsch D, Cierpicki T, Jelen F, Otlewski J. Canonical protein inhibitors of serine proteases. Cell Mol Life Sci 2003;60:2427-44
   PubMed Web of Science ®Google Scholar
• Delacourt C, Herigault S, Delclaux C, et al. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor. Am J Respir Cell Mol Biol 2002;26:290-7
   PubMed Web of Science ®Google Scholar
• Attucci S, Gauthier A, Korkmaz B, et al. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. J Pharmacol Exp Ther 2006;318:803-9
   PubMed Web of Science ®Google Scholar
• Wark PA. DX-890 (Dyax). IDrugs 2002;5(6):586-9
   Google Scholar
• Ladner RC; Dyax Corp. Protease inhibition. WO079096A2; 2007
   Google Scholar
• Schmidt R, Winter G. Wound Dresssing Composition, Especially for Delivery of Protease Inhibitors. WO037606A2; 2006
   Google Scholar
• Duranton J, Adam C, Bieth JG. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor. Biochemistry 1998;37(32):11239-45
   Google Scholar
• Lezdey J, Wachter A. Treatment of inflammation using 1-antichymotrypsin. US5008242A; 1991
   Google Scholar
• Lezdey J, Wachter AM; Sonoran Desert Chemicals. Treatment of inflammation. EP0512090B2; 2006
   Google Scholar
• Chmelar J, Oliveira CJ, Rezacova P, et al. A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation. Blood 2011;117:736-44
   PubMed Web of Science ®Google Scholar
• Demarco SJ, Moehle K, Henze H, et al. Polyphor Ltd., Universitat Zurich. Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity. US0054345A1; 2009
   Google Scholar
• Angelastro MR, Bey P, Doehrty NS, et al. Inhibitors of Cathepsin G and. Elastase for preventing connective tissue degradation. EP0587799B1; 1999
   Google Scholar
• Angelastro MR, Bey P, Doherty NS, et al. Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation. US5510333; 1996
   Google Scholar
• Fridkin M, Yavin EJ. Anti-inflammatory peptides derived from C-reactive protein. WO028182A1; 1997
   Google Scholar
• Shenvi AB, Kettner CA. α-Aminoboronic acid peptides. US4499082; 1985
   Google Scholar
• Zembower DE, Neudauer CL, Wick MJ, Ames MM. Peptide boronic acids. Versatile synthetic ligands for affinity chromatography of serine proteinases. Int J Pept Protein Res 1996;47:405-13
   Google Scholar
• Kettner CA, Shenvi AB. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids. J Biol Chem 1984;259:15106-14
   PubMed Web of Science ®Google Scholar
• Mucha A, Kafarski P, Berlicki L. Remarkable potential of the alpha-aminophosphonate/phosphinate structural motif in medicinal chemistry. J Med Chem 2011;54:5955-80
   PubMed Web of Science ®Google Scholar
• Mucha A, Drag M, Dalton JP, Kafarski P. Metallo-aminopeptidase inhibitors. Biochimie 2010;92:1509-29
   PubMed Web of Science ®Google Scholar
• Holden HM, Tronrud DE, Monzingo AF, et al. Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. Biochemistry 1987;26:8542-53
   PubMed Web of Science ®Google Scholar
• Hayek T, Attias J, Coleman R, et al. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res 1999;44:579-87
   PubMed Web of Science ®Google Scholar
• Matziari M, Dive V, Yiotakis A. Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors. Med Res Rev 2007;27:528-52
   PubMed Web of Science ®Google Scholar
• Vassiliou S, Mucha A, Cuniasse P, et al. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study. J Med Chem 1999;42:2610-20
   PubMed Web of Science ®Google Scholar
• Grzywa R, Sienczyk M. Phosphonic esters and their application of protease control. Curr Pharm Des 2013;19:1154-78
   Google Scholar
• Sienczyk M, Lesner A, Wysocka M, et al. New potent cathepsin G phosphonate inhibitors. Bioorg Med Chem 2008;16:8863-7
   Google Scholar
• Greco MN, Hawkins MJ, Powell ET, et al. Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design. J Am Chem Soc 2002;124:3810-11
   PubMed Web of Science ®Google Scholar
• Maryanoff BE, de Garavilla L, Greco MN, et al. Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation. Am J Respir Crit Care Med 2010;181:247-53
   Google Scholar
• de Garavilla L, Greco MN, Sukumar N, et al. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. J Biol Chem 2005;280:18001-7
   PubMed Web of Science ®Google Scholar
• Greco MN, Almond J, Harold R, et al. Novel phosphonic acid compounds as inhibitors of serine proteases. US0283221A1; 2012
   Google Scholar
• Suneela D, Dipmala P. Synthesis and pharmacokinetic profile of rhein- boswellic acid conjugate. Bioorg Med Chem Lett 2012;22:7582-7
   PubMed Web of Science ®Google Scholar
• Golbabaei S, Bazl R, Golestanian S, et al. Urease inhibitory activities of beta-boswellic acid derivatives. Daru 2013;21:2
   PubMed Web of Science ®Google Scholar
• Streffer JR, Bitzer M, Schabet M, et al. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology 2001;56:1219-21
   PubMed Web of Science ®Google Scholar
• Gerbeth K, Husch J, Fricker G, et al. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia 2013;84:99-106
   PubMed Web of Science ®Google Scholar
• Zhang YS, Xie JZ, Zhong JL, et al. Acetyl-11-keto-beta-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/beta-catenin signaling pathway. Biochim Biophys Acta 2013;1830:3604-15
   Google Scholar
• Sun Y, Liu D, Xi R, et al. Microbial transformation of acetyl-11-keto-beta-boswellic acid and their inhibitory activity on LPS-induced NO production. Bioorg Med Chem Lett 2013;23:1338-42
   PubMed Web of Science ®Google Scholar
• Liu JJ, Toy WC, Liu S, et al. Acetyl-keto-beta-boswellic acid induces lipolysis in mature adipocytes. Biochem Biophys Res Commun 2013;431:192-6
   PubMed Web of Science ®Google Scholar
• Rao AR, Veeresham C, Asres K. In vitro and in vivo inhibitory activities of four indian medicinal plant extracts and their major components on rat aldose reductase and generation of advanced glycation endproducts. Phytother Res 2013;27:753-60
   PubMed Web of Science ®Google Scholar
• Tausch L, Henkel A, Siemoneit U, et al. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. J Immunol 2009;183:3433-42
   PubMed Web of Science ®Google Scholar
• Werz O, Kapp J-F, Martin R. 2 Synthase and Cathepsin G. WO117987A2; 2009
   Google Scholar
• Ermolieff J, Duranton J, Petitou M, Bieth JG. Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin. Biochem J 1998;330:1369-74
   PubMed Web of Science ®Google Scholar
• Baici A, Diczhazi C, Neszmelyi A, et al. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin. Biochem Pharmacol 1993;46:1545-9
   Google Scholar
• Redini F, Tixier JM, Petitou M, et al. Inhibition of leucocyte elastase by heparin and its derivatives. Biochem J 1988;252:515-9
   PubMed Web of Science ®Google Scholar
• Kennedy TP; Carolinas HealthCare System. Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathespin. US5912237; 1999
   Google Scholar
• Ledoux D, Merciris D, Barritault D, Caruelle JP. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. FEBS Lett 2003;537:23-9
   PubMedGoogle Scholar
• Li P, Cebrian J, Carpentier G, et al. Effect of RG1192, a substituted dextran, on inflammatory response. Cell Mol Biol (Noisy-le-grand) 2003;49: Online Pub: OL409-13
   Google Scholar
• Alexakis C, Guettoufi A, Mestries P, et al. Heparan mimetic regulates collagen expression and TGF-beta1 distribution in gamma-irradiated human intestinal smooth muscle cells. FASEB J 2001;15:1546-54
   PubMed Web of Science ®Google Scholar
• Prestwich GD, Zhang J, Kennedy TP, et al. University of Utah Research Foundation. Alkylated semi-synthetic glysaminoglycan ethers, and methods of making and using thereof. US0317616A1; 2010
   Google Scholar
• He S, Kuang R, Venkataraman R, et al. Potent inhibition of serine proteases by heterocyclic sulfide derivatives of 1,2,5-thiadiazolidin-3-one 1,1 dioxide. Bioorg Med Chem 2000;8:1713-7
   PubMed Web of Science ®Google Scholar
• Groutas WC, Epp JB, Venkataraman R, et al. Design, synthesis, and in vitro inhibitory activity toward human leukocyte elastase, cathepsin G, and proteinase 3 of saccharin-derived sulfones and congeners. Bioorg Med Chem 1996;4:1393-400
   PubMed Web of Science ®Google Scholar
• Dunlap RP, Boaz NW, Mura AJ, et al. Sanofi. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof. US5874432; 1999
   Google Scholar
• Kuang R, Epp JB, Ruan S, et al. Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates. Bioorg Med Chem 2000;8:1005-16
   PubMed Web of Science ®Google Scholar
• Kulbachinskiy AV. Methods for selection of aptamers to protein targets. Biochemistry (Mosc) 2007;72:1505-18
   Google Scholar
• James W. Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery. Curr Opin Pharmacol 2001;1:540-6
   PubMedGoogle Scholar
• Palumbo M, Gatto B, Pescador R, et al. Gentium SPA. DNA-based Aptamers for Human Cathepin G. US0176814A1; 2008
   Google Scholar
• Ferro LI, Gatto B, Palumbo M, et al. DNA-based Aptamers for Human Cathepsin G. EP2236609A2; 2010
   Google Scholar